A Double-Blind, Placebo-Controlled (Sham Surgery), Randomized, Multicenter Study Evaluating CERE-110 Gene Delivery in Subjects with Mild to Moderate Alzheimer's Disease (CERE 110-3)

Grant

Date/time Interval

  • June 11, 2009 - June 10, 2011
  • Total Award Amount

  • 154750.00
  • Direct Costs

  • 123850.00
  • Sponsor Award Id

  • CTA 12-UAB (NGF) M-00 ADCSS
  • Contributor

  • Ray Watts   Principal Investigator